 |
인쇄하기
취소
|
Bioequivalence of combined preparations g to be compulsory
Published: 2008-12-04 07:00:00
Updated: 2008-12-04 07:00:00
Korean generic makers will have to conduct bioequivalence testing over combined preparations as the Korea Food and Drug Administration intends to evaluate the efficacy and safety of these medicines.
To this end, the KFDA will hold an information session on November 18 to establish a guideline for the bioequivalence testing.
“The plan is to enable the national health insurance to pay for m...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.